Brady Corp. (BRC) Reports Mixed Q3 Results; Cuts FY12 EPS Outlook
Tweet
Share
E-mailGet Alerts BRC Hot Sheet
Price: $93.95 -1.23%
EPS Growth %: +16.7%
Financial Fact:
Total operating expenses: 107.69M
Today's EPS Names:
OFLX, VAXX, NMRD, More
EPS Growth %: +16.7%
Financial Fact:
Total operating expenses: 107.69M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Brady Corp. (NYSE: BRC) reported Q3 EPS of $0.57, vs. the analyst estimate of $0.57. Revenue for the quarter came in at $331.6 million versus the consensus estimate of $342.09 million.
The company reduced its FY12 EPS guidance from $2.20-$2.40 to $2.15-$2.25.
For earnings history and earnings-related data on Brady Corp. (BRC) click here.
The company reduced its FY12 EPS guidance from $2.20-$2.40 to $2.15-$2.25.
For earnings history and earnings-related data on Brady Corp. (BRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Dare Bioscience (DARE) Tops Q2 EPS by 11c
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
